4
Changes in Ownership
MapLight Therapeutics, Inc. Filed Acc 0001728746-26-000014
Chief Scientific Officer sold 22,082 shares at $12.54 ($276,908)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Lillie James Woodruff · Chief Scientific Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-08-03 | Sale : show line 1 in the form 10b5-1 | −22,082 | $12.54 | $276,908 | 202,380 | D |
| Open-market sales · 22,082 sh · avg $12.54 · $276,908 | ||||||
Loading xslF345X06/form4-08052026_120851.xml…